Today's Trend
Novavax, Inc. (NASDAQ: NVAX) is under pressure today, with investors reacting to a mix of index rebalancing, cautious options activity, and mostly modestly positive analyst revisions.
- Novavax was removed from several major Russell growth and small-cap indices, which could reduce demand from passive index funds and force benchmark-tracking investors to trim exposure. Novavax (NVAX) Dropped From Major Russell Growth Indices And Why It Matters
- Options trading turned bearish, with unusually large put buying signaling that some traders are positioning for downside or hedging against further weakness.
- Zacks Research raised its earnings estimates for Novavax for Q1 2027, Q2 2027, and FY2027 and maintained a Strong-Buy rating, but the revisions were not enough to offset the index-removal headline.
- Recent commentary also noted Novavax has outperformed some peers despite a recent pullback, suggesting sentiment remains mixed rather than uniformly bearish. Novavax (NVAX) Suffers a Larger Drop Than the General Market: Key Insights
Overall, NVAX appears to be trading lower on concerns that index removals may dampen institutional demand, with bearish options activity reinforcing that view, while analyst estimate increases provide only limited support.